David Lawrence Lonczak insider trades: Drugstore Com (DSCM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 25, 2011 | DSCM | ↓ Sell | 127,142 | $3.90 | $496K | Direct | Mar 29, 2011 (4d) |
| Jun 11, 2010 | DSCM | ↓ Sell | 567 | $3.43 | $2K | Direct | Jun 15, 2010 (4d) |
| Apr 6, 2010 | DSCM | ↓ Sell | 5,088 | $3.79 | $19K | Direct | Apr 8, 2010 (2d) |
| Oct 6, 2009 | DSCM | ↓ Sell | 5,219 | $2.27 | $12K | Direct | Oct 8, 2009 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David Lawrence Lonczak's insider trades
David Lawrence Lonczak is VP, Chief Marketing Officer at Drugstore Com (DSCM). Since Oct 6, 2009, David has reported no open-market purchases and 4 sales worth $529K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), shares withheld for taxes (3 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every DSCM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.